Complete Filing Data
OnKure Therapeutics, Inc. reported Stockholders Equity of $56.18 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean OnKure Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$59.5M | -$52.7M | -$35.3M | -$52.0M | -$39.8M | -$19.5M |
| Research And Development Expense | $48.3M | $43.8M | $32.1M | $37.7M | $28.2M | $15.9M |
| Operating Income Loss | -$63.0M | -$54.4M | -$36.9M | -$53.8M | -$39.8M | -$19.6M |
| Operating Expenses | $63.0M | $54.4M | $36.9M | $53.8M | $39.8M | $19.6M |
| General And Administrative Expense | $14.7M | $10.6M | $4.8M | $16.1M | $11.6M | $3.6M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $51.0K | -$77.0K | $34.0K | -$3.0K | ||
| Comprehensive Income Net Of Tax | -$77.3M | -$52.0M | -$39.7M | -$19.5M | ||
| Other Nonoperating Income Expense | $5.7M | $1.9M | $48.0K | |||
| Other Comprehensive Income Loss Net Of Tax | $51.0K | -$77.0K | $34.0K | -$3.0K | ||
| Interest Income Expense Net | $3.4M | $1.7M | $1.6M | |||
| Other Nonoperating Income | $48.0K | $87.0K | ||||
| Operating Lease Right Of Use Asset Amortization Expense Lease Modification And Impairment | -$441.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$14.7M | -$15.4M | -$15.9M | -$17.4M | -$11.6M | -$14.1M | -$9.5M | -$19.2M | -$19.5M | -$15.1M | -$13.0M | -$12.3M | -$13.0M | -$12.7M | -$9.2M | -$7.2M | -$5.1M | -$3.7M | -$4.4M |
| Research And Development Expense | $11.9M | $12.6M | $13.0M | $10.1M | $10.8M | $8.6M | $13.6M | $14.4M | $11.0M | $9.9M | $8.1M | $9.3M | $9.3M | $6.3M | $5.5M | $4.4M | $2.8M | $3.6M | |
| Operating Income Loss | -$15.5M | -$16.3M | -$17.0M | -$11.5M | -$14.3M | -$9.8M | -$20.9M | -$21.0M | -$16.1M | -$13.8M | -$12.4M | -$13.0M | -$12.8M | -$9.2M | -$7.2M | -$5.1M | -$3.7M | -$4.5M | |
| Operating Expenses | $15.5M | $16.3M | $17.0M | $11.5M | $14.3M | $9.8M | $20.9M | $21.0M | $16.1M | $13.8M | $12.4M | $13.0M | $12.8M | $9.2M | $7.2M | $5.1M | $3.7M | $4.5M | |
| General And Administrative Expense | $3.6M | $3.7M | $4.0M | $1.4M | $3.6M | $1.3M | $7.3M | $6.6M | $5.1M | $3.9M | $4.3M | $3.7M | $3.4M | $2.9M | $1.7M | $668.0K | $882.0K | $924.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $15.0K | -$1.0K | -$20.0K | $10.0K | -$43.0K | $55.0K | -$194.0K | $104.0K | $30.0K | $12.0K | $5.0K | -$4.0K | -$6.0K | $7.0K | |||||
| Comprehensive Income Net Of Tax | -$3.7M | -$5.4M | -$8.4M | -$19.2M | -$19.6M | -$15.1M | -$13.2M | -$12.2M | -$13.0M | -$12.7M | -$9.2M | -$7.2M | -$5.1M | -$3.7M | -$4.4M | ||||
| Other Nonoperating Income Expense | $972.0K | $1.0M | $1.1M | $1.7M | $1.5M | $1.0M | $833.0K | $119.0K | -$21.0K | $17.0K | $12.0K | $2.0K | |||||||
| Other Comprehensive Income Loss Net Of Tax | $15.0K | -$1.0K | -$20.0K | $10.0K | -$43.0K | $55.0K | -$194.0K | $104.0K | $30.0K | $12.0K | $5.0K | ||||||||
| Interest Income Expense Net | $802.0K | $934.0K | -$44.0K | $204.0K | |||||||||||||||
| Other Nonoperating Income | $17.0K | $12.0K | $2.0K | $5.0K | $12.0K | $71.0K | |||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense Lease Modification And Impairment | -$120.0K | -$143.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $56.2M | $103.8M | -$101.8M | -$54.4M | $147.2M | -$42.1M | -$23.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $59.1M | $110.8M | $29.9M | $11.5M | $124.7M | $53.6M | $17.5M |
| Retained Earnings Accumulated Deficit | -$214.2M | -$154.7M | -$102.1M | -$136.7M | -$84.7M | -$45.0M | |
| Cash And Cash Equivalents At Carrying Value | $59.1M | $110.8M | $29.9M | $19.9M | $124.7M | $53.6M | |
| Property Plant And Equipment Net | $618.0K | $1.0M | $1.4M | $453.0K | $212.0K | $69.0K | |
| Prepaid Expense And Other Assets Current | $1.8M | $2.2M | $3.9M | $5.2M | $6.1M | $1.4M | |
| Liabilities Current | $5.9M | $10.5M | $7.3M | $7.1M | $6.2M | $4.6M | |
| Liabilities And Stockholders Equity | $62.1M | $114.9M | $35.7M | $108.2M | $154.0M | $55.2M | |
| Liabilities | $5.9M | $11.1M | $7.8M | $8.2M | $6.8M | $4.6M | |
| Assets Current | $60.8M | $113.0M | $33.8M | $106.4M | $153.7M | $55.0M | |
| Assets | $62.1M | $114.9M | $35.7M | $108.2M | $154.0M | $55.2M | |
| Accounts Payable Current | $1.4M | $3.0M | $3.4M | $1.9M | $2.0M | $908.0K | |
| Other Assets Noncurrent | $273.0K | $109.0K | $58.0K | $84.0K | $78.0K | $127.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$51.7M | $80.9M | $18.3M | -$104.7M | $71.0M | $36.1M | |
| Accrued Liabilities Current | $3.7M | $4.8M | $4.2M | $3.7M | |||
| Operating Lease Right Of Use Asset | $387.0K | $770.0K | $478.0K | $1.3M | |||
| Operating Lease Liability Current | $549.0K | $536.0K | $208.0K | $404.0K | |||
| Operating Lease Liability Noncurrent | $549.0K | $466.0K | $1.1M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.8M | $817.0K | -$202.0K | $17.0K | |||
| Short Term Investments | $81.2M | $23.0M | |||||
| Deferred Compensation Liability Classified Noncurrent | $29.0K | $444.0K | |||||
| Common Stock Value | $3.0K | $3.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$43.0K | $34.0K | |||||
| Gain Loss On Disposition Of Assets1 | -$54.0K | -$17.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $219.0K | $1.7M | |||||
| Operating Lease Right Of Use Asset Amortization Expense | $383.0K | $203.0K | $143.0K | ||||
| Other Liabilities Noncurrent | $12.0K | $167.0K | |||||
| Non Cash Lease Expense | $355.0K | $441.0K | |||||
| Deferred Rent Credit Noncurrent | $167.0K | $36.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $66.4M | $78.2M | $90.6M | -$135.1M | -$123.6M | -$111.3M | $114.9M | $132.5M | $87.1M | $112.0M | $124.2M | $135.3M | $156.2M | $167.6M | -$48.7M | -$36.0M | -$31.0M | -$27.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $70.3M | $83.4M | $96.7M | $8.0M | $18.6M | $19.2M | $11.7M | $9.1M | $30.4M | $62.1M | $118.3M | $121.1M | $126.4M | $140.4M | $91.2M | $11.8M | $16.3M | $18.3M | ||
| Retained Earnings Accumulated Deficit | -$200.7M | -$186.0M | -$170.6M | -$236.0M | -$232.3M | -$226.9M | -$190.5M | -$171.3M | -$151.8M | -$123.1M | -$110.1M | -$97.8M | -$74.1M | -$61.4M | -$97.8M | |||||
| Cash And Cash Equivalents At Carrying Value | $70.3M | $83.4M | $96.7M | $60.7M | $36.0M | $20.4M | $11.7M | $9.1M | $30.4M | $62.1M | $118.3M | $121.1M | $126.4M | $140.4M | $91.2M | |||||
| Property Plant And Equipment Net | $720.0K | $821.0K | $925.0K | $59.0K | $81.0K | $102.0K | $529.0K | $554.0K | $581.0K | $241.0K | $236.0K | $237.0K | $200.0K | $85.0K | $81.0K | |||||
| Prepaid Expense And Other Assets Current | $1.2M | $1.2M | $1.5M | $331.0K | $1.3M | $1.1M | $3.2M | $3.6M | $3.2M | $4.9M | $5.2M | $4.1M | $4.9M | $3.8M | $2.3M | |||||
| Liabilities Current | $6.2M | $7.6M | $8.8M | $3.2M | $1.3M | $2.8M | $13.6M | $13.7M | $10.5M | $9.5M | $8.3M | $7.9M | $6.4M | $3.3M | $3.9M | |||||
| Liabilities And Stockholders Equity | $72.8M | $86.1M | $99.9M | $77.6M | $78.7M | $84.6M | $130.4M | $148.0M | $98.9M | $122.5M | $133.6M | $144.4M | $162.9M | $171.3M | $95.3M | |||||
| Liabilities | $6.4M | $7.9M | $9.2M | $3.6M | $1.8M | $3.4M | $15.4M | $15.5M | $11.8M | $10.5M | $9.5M | $9.1M | $6.7M | $3.8M | $4.0M | |||||
| Assets Current | $71.5M | $84.6M | $98.2M | $77.0M | $78.0M | $83.9M | $128.8M | $146.3M | $97.0M | $121.0M | $132.0M | $142.7M | $162.7M | $171.1M | $93.6M | |||||
| Assets | $72.8M | $86.1M | $99.9M | $77.6M | $78.7M | $84.6M | $130.4M | $148.0M | $98.9M | $122.5M | $133.6M | $144.4M | $162.9M | $171.3M | $95.3M | |||||
| Accounts Payable Current | $1.3M | $2.4M | $2.3M | $237.0K | $64.0K | $676.0K | $2.5M | $1.8M | $1.8M | $2.2M | $1.6M | $1.6M | $1.3M | $434.0K | $556.0K | |||||
| Other Assets Noncurrent | $104.0K | $116.0K | $109.0K | $147.0K | $153.0K | $64.0K | $81.0K | $79.0K | $81.0K | $79.0K | $78.0K | $78.0K | $78.0K | $78.0K | $1.7M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.1M | -$10.6M | $10.5M | -$3.6M | $37.6M | $778.0K | ||||||||||||||
| Accrued Liabilities Current | $4.7M | $5.9M | $7.0M | $725.0K | $953.0K | $1.8M | $10.8M | $11.6M | $8.3M | $6.9M | $6.4M | $5.9M | $5.1M | $2.9M | $3.4M | |||||
| Operating Lease Right Of Use Asset | $485.0K | $581.0K | $676.0K | $440.0K | $493.0K | $546.0K | $1.0M | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | ||||||||
| Operating Lease Liability Current | $567.0K | $556.0K | $546.0K | $286.0K | $331.0K | $331.0K | $325.0K | $318.0K | $363.0K | $410.0K | $408.0K | $457.0K | ||||||||
| Operating Lease Liability Noncurrent | $120.0K | $267.0K | $409.0K | $379.0K | $492.0K | $576.0K | $812.0K | $897.0K | $979.0K | $943.0K | $1.1M | $1.1M | ||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $906.0K | $770.0K | -$1.0K | $15.0K | ||||||||||||||||
| Short Term Investments | $16.0M | $40.7M | $62.5M | $75.3M | $113.9M | $133.6M | $63.4M | $53.9M | $8.6M | $17.6M | $31.3M | $27.0M | ||||||||
| Deferred Compensation Liability Classified Noncurrent | $0.00 | $8.0K | $7.0K | $7.0K | $1.1M | $876.0K | $324.0K | $66.0K | $55.0K | $57.0K | $284.0K | $363.0K | ||||||||
| Common Stock Value | $0.00 | $3.0K | $3.0K | $0.00 | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.0K | -$13.0K | -$12.0K | $8.0K | -$21.0K | -$31.0K | $12.0K | -$26.0K | $168.0K | $64.0K | $17.0K | $5.0K | ||||||||
| Gain Loss On Disposition Of Assets1 | -$16.0K | -$3.0K | ||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $1.5M | |||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $94.0K | $37.0K | ||||||||||||||||||
| Other Liabilities Noncurrent | $40.0K | $40.0K | $40.0K | |||||||||||||||||
| Non Cash Lease Expense | $67.0K | $120.0K | ||||||||||||||||||
| Deferred Rent Credit Noncurrent | $98.0K | $54.0K | $32.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $447.0K | $459.0K | $417.0K | $88.0K | $50.0K | $37.0K |
| Share Based Compensation | $11.6M | $4.5M | $199.0K | $4.3M | $3.9M | $393.0K |
| Net Cash Provided By Used In Operating Activities | -$51.8M | -$51.1M | -$34.5M | -$47.4M | -$38.0M | -$18.5M |
| Net Cash Provided By Used In Investing Activities | -$46.0K | $15.9M | -$246.0K | -$57.8M | -$23.4M | $7.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$289.0K | -$2.3M | $1.5M | -$878.0K | $4.7M | $967.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$4.5M | -$5.9M | $1.7M | $518.0K | $1.8M | $1.5M |
| Payments To Acquire Property Plant And Equipment | $46.0K | $52.0K | $246.0K | $346.0K | $198.0K | $24.0K |
| Net Cash Provided By Used In Financing Activities | $163.0K | $116.1M | $53.1M | $471.0K | $132.4M | $47.3M |
| Increase Decrease In Operating Lease Liability | -$536.0K | -$281.0K | -$210.0K | -$437.0K | ||
| Stock Issued During Period Value Share Based Compensation | $730.0K | $278.0K | $560.0K | |||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $242.0M | $44.1M | $8.2M | $7.4M | ||
| Payments To Acquire Available For Sale Securities Debt | $231.3M | $101.6M | $31.4M | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 26.0K | 65.0K | 278.0K | 556.0K | ||
| Proceeds From Issuance Of Common Stock | $193.0K | $84.6M | ||||
| Proceeds From Stock Options Exercised | $26.0K | $556.0K | $87.0K | |||
| Increase Decrease In Deferred Rent | $131.0K | -$5.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $108.0K | $117.0K | $118.0K | $114.0K | $115.0K | $114.0K | $41.0K | $19.0K | $13.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | ||||
| Share Based Compensation | $2.7M | $107.0K | $1.2M | $1.1M | $471.0K | $92.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$14.0M | -$10.6M | -$9.0M | -$9.0M | -$8.6M | -$4.4M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$18.0K | -$9.0K | $18.5M | $5.4M | -$25.0K | $5.2M | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$731.0K | -$437.0K | -$2.0M | -$2.0M | $929.0K | $137.0K | ||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.7M | -$1.7M | $3.4M | $1.3M | -$927.0K | $36.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $18.0K | $9.0K | $172.0K | $44.0K | $25.0K | $1.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | -$77.0K | $10.0K | $1.0M | $6.0K | $46.2M | $26.0K | ||||||||||||
| Increase Decrease In Operating Lease Liability | -$130.0K | -$50.0K | -$137.0K | -$108.0K | ||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $173.0K | $282.0K | $99.0K | $41.0K | $6.0K | $235.0K | $14.0K | $139.0K | ||||||||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $59.0M | $47.0M | $21.5M | $5.2M | ||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $45.2M | $28.3M | $16.0M | |||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 10.0K | |||||||||||||||||
| Proceeds From Issuance Of Common Stock | $1.0M | $6.0K | $187.0K | |||||||||||||||
| Proceeds From Stock Options Exercised | $187.0K | $26.0K | ||||||||||||||||
| Increase Decrease In Deferred Rent | -$2.0K | -$1.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.40 | -$15.28 | -$124.41 | -$2.12 | -$2.19 | -$9.60 |
| Weighted Average Number Of Shares Outstanding Basic | 13.5M | 3.4M | 283.8K | 24.5M | 18.1M | 2.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 13.5M | 3.4M | 283.8K | 24.5M | 18.1M | 2.0M |
| Earnings Per Share Basic | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 | $-9.60 |
| Common Stock Shares Authorized | 210.0M | 210.0M | 200.0M | 200.0M | 105.0M | |
| Common Stock Shares Outstanding | 24.7M | 24.5M | 2.1M | |||
| Common Stock Shares Issued | 24.7M | 24.5M | 2.1M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $19.06 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.09 | -$1.14 | -$1.19 | -$36.55 | -$44.82 | -$30.37 | -$5.68 | -$0.65 | -$0.60 | -$0.53 | -$0.50 | -$0.53 | -$0.52 | -$0.43 | -$3.48 | -$2.48 | -$1.82 | -$2.20 | ||
| Weighted Average Number Of Shares Outstanding Basic | 13.5M | 13.5M | 13.4M | 316.1K | 315.5K | 314.0K | 3.4M | 30.2M | 25.0M | 24.5M | 24.5M | 24.5M | 24.4M | 21.4M | 2.1M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 13.5M | 13.5M | 13.4M | 316.1K | 315.5K | 314.0K | 3.4M | 30.2M | 25.0M | 24.5M | 24.5M | 24.5M | 24.4M | 21.4M | 2.1M | |||||
| Earnings Per Share Basic | $-1.09 | $-1.14 | $-1.19 | $-36.55 | $-44.82 | $-30.37 | $-5.68 | $-0.65 | $-0.60 | $-0.53 | $-0.50 | $-0.53 | $-0.52 | $-0.43 | $-3.48 | |||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 105.0M | |||||||
| Common Stock Shares Outstanding | 3.3M | 33.4M | 33.4M | 3.3M | 33.9M | 33.8M | 25.1M | 24.5M | 24.5M | 24.5M | 24.4M | 24.3M | 2.1M | |||||||
| Common Stock Shares Issued | 3.3M | 33.4M | 33.4M | 3.3M | 33.9M | 33.8M | 25.1M | 24.5M | 24.5M | 24.5M | 24.4M | 24.3M | 2.1M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 24.4M | 21.4M | 2.1M | 2.1M | 2.0M | 2.0M | ||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.6M | $4.5M | $199.0K | $4.3M | $3.9M | $393.0K |
| Additional Paid In Capital | $270.4M | $258.6M | $209.0K | $236.7M | $231.9M | $2.8M |
| Stock Issued During Period Value Stock Options Exercised | $26.0K | $507.0K | $87.0K | |||
| Fair Value Changes Of Share Based Performance Award | -$22.0K | -$415.0K | $444.0K | |||
| Interest Income Operating | $3.4M | $2.0M | $1.6M | |||
| Stock Issued During Period Value New Issues | $65.5M | $84.5M | ||||
| Stock Issued During Period Shares Stock Options Exercised | 0.00 | 2.5K | 238.5K | |||
| Capital Expenditures Incurred But Not Yet Paid | $5.0K | |||||
| Interest And Other Expense | $8.0K | $300.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.0M | $2.9M | $2.7M | $2.5M | $77.0K | $1.8M | $107.0K | $1.4M | $1.2M | $1.2M | $990.0K | $1.0M | $1.1M | $1.1M | $854.0K | $471.0K | $84.0K | $88.0K | $92.0K |
| Additional Paid In Capital | $267.2M | $264.2M | $261.3M | $310.0M | $309.1M | $308.2M | $305.5M | $303.9M | $238.9M | $235.2M | $234.1M | $233.0M | $230.3M | $228.9M | $3.5M | ||||
| Stock Issued During Period Value Stock Options Exercised | $6.0K | $10.0K | $10.0K | $6.0K | $220.0K | $139.0K | $51.0K | $26.0K | |||||||||||
| Fair Value Changes Of Share Based Performance Award | $295.0K | -$387.0K | |||||||||||||||||
| Interest Income Operating | $804.0K | $934.0K | $1.1M | $174.0K | $230.0K | $295.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $65.5M | $1.0M | $84.5M | ||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 0.00 | 713.00 | 95.1K | ||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $2.0K | ||||||||||||||||||
| Interest And Other Expense | $2.0K | $218.0K | $26.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.